Significant Improvement in AI Investment Returns Enhances Earnings Prospects, Bullish Logic for Blue-Chip UnitedHealth Is Reshaping Jul 3, 2026 Life Science
Pharmaceutical Giant AbbVie Makes a Major Bet on a New Immunotherapy, and Its Dividend Growth Record Attracts Income-Focused Investors Jul 1, 2026 Life Science
Anthropic Launches Claude Science to Enter Life Sciences, AI Drug Discovery Stocks Tumble in Response Jun 30, 2026 Life Science
Innovative Pipeline Supports Long-Term Value, Moderna Still Has Upside After Doubling in Price Jun 26, 2026 Life Science
Impressive Clinical Trial Data Drives Intellia Therapeutics Up 70% This Year Jun 25, 2026 Life Science
Mid-Cap Biotech Viking Therapeutics Could Emerge as a Potential Challenger to Eli Lilly and Novo Nordisk Jun 23, 2026 Life Science
Healthcare Expenditures Continue to Grow, Three Leading Stocks Lead the 2026 Investment Race Jun 16, 2026 Life Science
The Stock Price of UnitedHealth Group Still Falls More Than 30% from Two Years Ago, and Policy Dependency Becomes a Key Investment Consideration Jun 12, 2026 Life Science
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year Jun 11, 2026 Life Science
Market Embraces R&D Pipeline Progress, Moderna’s Stock Soars on Cancer Vaccine Prospects Jun 9, 2026 Life Science
